Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Prophylactic Effects of Recombinant Thrombomodulin Against Sclerodermatous Chronic Graft-Versus-Host Disease in a Rodent Model

Toshihiro Fujiki, MD, Rie Kuroda, MD, Hideaki Maeba, MD, Kazuhiro Noguchi, MD, Masaki Fukuda, MD, Shintaro Mase, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Akihiro Yachie, MD PhD, Masayuki Nagasawa, MD PhD, Ryosei Nishimura, MD PhD

Blood (2017) 130 (Supplement 1): 1895.

https://doi.org/10.1182/blood.V130.Suppl_1.1895.1895

Published: 2017

Journal Articles

Third Party Cytokine-Induced Killer Cells Eliminate Highly Activated T-Cells, Leading to Protect from Murine Lethal Graft-Versus-Host Disease

Rie Kuroda, MD, Shintaro Mase, MD, Hideaki Maeba, MD, Toshihiro Fujiki, MD, Masaki Fukuda, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2016) 128 (22): 2158.

https://doi.org/10.1182/blood.V128.22.2158.2158

Published: 2016

Journal Articles

Third Party Cytokine-Induced Killer Cells Protect from Murine Lethal Graft-Versus-Host Disease

Rie Kuroda, MD, Shintaro Mase, MD, Toshihiro Fujiki, MD, Hideaki Maeba, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Masaki Fukuda, MD, Shoichi Koizumi, MD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2015) 126 (23): 3092.

https://doi.org/10.1182/blood.V126.23.3092.3092

Published: 2015

Journal Articles

High Concentration of Immunoglobulin Allows Long-Lasting Suppression of Allo-Immune Reaction By Directly Inhibiting T-Cell Activation

Hideaki Maeba, MD, Rie Kuroda, MD, Masaki Fukuda, MD, Toshihiro Fujiki, MD, Shintaro Mase, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 4983.

https://doi.org/10.1182/blood.V124.21.4983.4983

Published: 2014

Journal Articles

Highly Elevated IL-18 Is a Reliable Predictor of Progression to Hemophagocytic Syndrome in the Patients with Langerhans Cell Histiocytosis

Yasuhiro Ikawa, MD PhD, Raita Araki, MD, Toshihiro Fujiki, MD, Masaki Fukuda, MD, Shintaro Mase, MD, Rie Kuroda, MD, Hideaki Maeba, MD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 2736.

https://doi.org/10.1182/blood.V124.21.2736.2736

Published: 2014

Journal Articles

Thymic 18 F-FDG PET/CT Findings in Pediatric Malignant Lymphoma after Chemotherapy: Differentiation of Long-Lasting Thymic Hyperplasia from Lymphoma Recurrence

Toshihiro Fujiki, MD, Hideaki Maeba, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Rie Kuroda, MD, Shintaro Mase, MD, Masaki Fukuda, MD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 5409.

https://doi.org/10.1182/blood.V124.21.5409.5409

Published: 2014

Journal Articles

Simplified Monitoring of CD4 T-Cell Receptor Repertoire Provides Effective Management Strategies in the Patients with Persistent or Recurrent Graft-Versus-Host Disease

Rie Kuroda, MD, Shintaro Mase, MD, Hideaki Maeba, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Toshihiro Fujiki, MD, Masaki Fukuda, MD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 1162.

https://doi.org/10.1182/blood.V124.21.1162.1162

Published: 2014

NARROW

Prophylactic Effects of Recombinant Thrombomodulin Against Sclerodermatous Chronic Graft-Versus-Host Disease in a Rodent Model

Third Party Cytokine-Induced Killer Cells Eliminate Highly Activated T-Cells, Leading to Protect from Murine Lethal Graft-Versus-Host Disease

Third Party Cytokine-Induced Killer Cells Protect from Murine Lethal Graft-Versus-Host Disease

High Concentration of Immunoglobulin Allows Long-Lasting Suppression of Allo-Immune Reaction By Directly Inhibiting T-Cell Activation

Highly Elevated IL-18 Is a Reliable Predictor of Progression to Hemophagocytic Syndrome in the Patients with Langerhans Cell Histiocytosis

Thymic 18 F-FDG PET/CT Findings in Pediatric Malignant Lymphoma after Chemotherapy: Differentiation of Long-Lasting Thymic Hyperplasia from Lymphoma Recurrence

Simplified Monitoring of CD4 T-Cell Receptor Repertoire Provides Effective Management Strategies in the Patients with Persistent or Recurrent Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Prophylactic Effects of Recombinant Thrombomodulin Against Sclerodermatous Chronic Graft-Versus-Host Disease in a Rodent Model

Third Party Cytokine-Induced Killer Cells Eliminate Highly Activated T-Cells, Leading to Protect from Murine Lethal Graft-Versus-Host Disease

Third Party Cytokine-Induced Killer Cells Protect from Murine Lethal Graft-Versus-Host Disease

High Concentration of Immunoglobulin Allows Long-Lasting Suppression of Allo-Immune Reaction By Directly Inhibiting T-Cell Activation

Highly Elevated IL-18 Is a Reliable Predictor of Progression to Hemophagocytic Syndrome in the Patients with Langerhans Cell Histiocytosis

Thymic 18 F-FDG PET/CT Findings in Pediatric Malignant Lymphoma after Chemotherapy: Differentiation of Long-Lasting Thymic Hyperplasia from Lymphoma Recurrence

Simplified Monitoring of CD4 T-Cell Receptor Repertoire Provides Effective Management Strategies in the Patients with Persistent or Recurrent Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only